Supplement Guide · Foundations and Homeostasis

When supplements make sense, and when they get in the way

Your body does not store nutrients, it regulates them. Turn one dial and the others move with it. Why more is therefore rarely better, and when targeted topping up can still change a great deal.

Homeostasis Antagonisms The dose principle Measure, do not guess Honest evidence Safety first
SJ Shukri Jarmoukli · Physician · Area of focus: integrative medicine · ViveCura Berlin
My starting point

I am not against supplements. I am against supplements without a question behind them. A nutrient is not a switch. It is a player. And whoever swaps out a player changes the whole game, not just one position.

Take a look at your bathroom shelf. Or at that drawer in the kitchen. How many tins are standing there? And for how many of them could you say in one sentence why exactly you take them and when you will stop?

I ask this question almost every day in my consultations. It is not meant as a reproach. I ask it of myself in the same way.

The most common answer is: because it is supposed to be good. Because someone recommended it. Because I feel like I need something. Those are entirely understandable reasons. They are simply not a medical indication, and that is exactly where the topic starts to get interesting.

This text is the foundation article for everything that follows in this guide. It does not answer the question of which product is best. It answers the question before that: when can a capsule move something, when does it move nothing, and when does it move something in the wrong direction?

What you will find here

  • Why your body regulates nutrients instead of storing them
  • How the large prevention trials can be placed in context
  • Why that does not mean supplements are useless
  • The most important antagonisms at a glance
  • Covering requirements and high-dose therapy are two worlds
  • Why topping up can be more often justified today
  • The four KPNI lenses on a single nutrient
  • The three questions before every supplement
This is how I mark the level of evidence in this text: Clinical trial in humans Observation, review in humans Animal study Cell culture, mechanism Database comparison

Your body has no warehouse, it has a feedback loop

Picture an old radiator with a thermostat. You turn the dial, it gets warmer. You keep turning, it does not get twice as warm. At some point the valve throttles back, and the rest of the energy goes into the wall.

Your body behaves in a similar way with almost every micronutrient. It has sensors, transporters and brakes. It decides at the gut wall how much gets in at all. It decides in the kidney how much goes back out. And it decides in the cell how much is needed right now.

That is homeostasis. Not a store, but a feedback loop.

A particularly clear example is iron. Your body has a hormone called hepcidin, which you can picture as a doorman. Hepcidin binds to ferroportin, the only known exit through which iron passes from the gut cells into the blood. Once hepcidin binds, that exit is broken down. Supply can dry up even though there is still iron sitting in the gut.

Cell culture, mechanism Why inflammation can slow iron absorption

A nephrology group put together what is known about the regulation of iron balance. It describes hepcidin as the central hormone of systemic iron regulation, one that is turned up during inflammation.

The mechanism: hepcidin binds to ferroportin and triggers its uptake into the cell and its breakdown. Iron absorption from the gut can be inhibited as a result, and release from storage cells can be throttled.

What this means in practice: with silent inflammation, a higher iron dose can achieve less than hoped. Not because too little was swallowed, but because the feedback loop closes. This is why an iron value always belongs together with an inflammation marker.

Afsar RE et al. Mol Cell Biochem. 2021. DOI: 10.1007/s11010-021-04168-4

This principle does not apply to iron alone. In varying forms it applies to zinc, to calcium, to magnesium, to vitamin D. For each of these substances the body has feedback mechanisms that it does not like to have overridden from the outside.

Reframe

The question is not: how much do I swallow? The question is: how much arrives, and what does that do to the other values?

That sounds technical. But it is the difference between an intervention that changes something and expensive urine.

And now you know why I ask about the feedback loop first with every product, and only then about the dose.

The large prevention trials: sobering, and easily oversimplified

You may have seen the headline: supplements do nothing. Sometimes it says: they even do harm. Both rest on real, large and well-conducted trials. And both fall short.

I will show you the numbers, because I believe you can place them in context.

Clinical trial in humans The Cochrane analysis on antioxidants

An international author team evaluated 78 randomised trials with 296,707 participants that had tested beta carotene, vitamin A, vitamin C, vitamin E or selenium against placebo.

Overall, no advantage for mortality was found. In the 56 trials with a low risk of bias there was even a slightly increased risk, especially for beta carotene and vitamin E. For vitamin C and selenium there was no significant effect in either direction.

What this means for you: antioxidants given broadly and long term without prior measurement are not a way to extend life. That is among the best supported statements this field has to offer.

Bjelakovic G et al. Cochrane Database Syst Rev. 2012. DOI: 10.1002/14651858.CD007176.pub2

It becomes even clearer in two individual trials that still echo through the field today.

Clinical trial in humans When an antioxidant did the opposite

In Finland, 29,133 male smokers between 50 and 69 years of age received alpha-tocopherol, beta carotene, both or placebo over five to eight years. The expectation was a drop in the lung cancer rate.

The opposite was observed. In the beta carotene group the lung cancer rate was 18 percent higher than in the comparison group, and overall mortality was 8 percent higher. Two decades later the SELECT trial with 35,533 men showed that vitamin E at 400 International Units daily increased prostate cancer risk compared with placebo.

What this means for you: an isolated substance, pulled out of a food and given in a high dose, does not behave like the food. These two trials are the reason I am cautious with high single doses.

The Alpha-Tocopherol, Beta Carotene Cancer Prevention Study Group. N Engl J Med. 1994. DOI: 10.1056/NEJM199404143301501 · Klein EA et al. JAMA. 2011. DOI: 10.1001/jama.2011.1437

With the classic multivitamin the picture looks somewhat different, though not euphoric either.

An evaluation of three large US cohorts with a combined 390,124 adults who had no cancer or chronic disease at baseline found no mortality advantage over up to 27 years for people who took a daily multivitamin. The US Preventive Services Task Force came to a similar conclusion in 2022 and clearly advises against beta carotene and vitamin E for cancer and cardiovascular prevention. For multivitamins it rates the evidence as insufficient to weigh benefit and harm against each other.

Someone who is full does not get fuller from another meal. Most of these trials never measured nutrient status at baseline. Whether the participants had a gap is therefore open. They answer a different question from the one most readers assume.

And now comes the part the headlines like to leave out. There are signals in the other direction too.

Clinical trial in humans The small signals in favour of the multivitamin

In the Physicians Health Study II, 14,641 male doctors aged 50 and over received a daily multivitamin or placebo over a median of eleven years. The rate of cancer overall was slightly lower in the multivitamin group, with a hazard ratio of 0.92.

And in COSMOS a team pooled three sub-studies with a combined 5,203 older adults. For general cognitive performance and episodic memory a small but statistically robust advantage was found.

What this means for you: the effect is small and it replaces nothing. But it does show that a blanket it does nothing would be just as imprecise as a blanket everyone benefits.

Gaziano JM et al. JAMA. 2012. DOI: 10.1001/jama.2012.14641 · Vyas CM et al. Am J Clin Nutr. 2024. DOI: 10.1016/j.ajcnut.2023.12.011
What follows from the null results, and what does not

These trials do not show that nutrients are unimportant. They show that the watering can is a poor tool.

If you supplement a population across the board without measuring first, in the best case you measure nothing. If you give the same substance in a targeted way to someone with a documented gap, that is a different study, and one that has often not been done at all.

And now you know why, with headlines on this topic, my first question is always: who was actually studied here?

When one dial turns another

Now we come to the point I meet most often in daily practice and that gets discussed least.

You take something for A. And you move B along with it, without noticing.

Picture a mobile above a cot. You pull on one figure and all the others move. This is not a metaphor for some marginal phenomenon. It is the basic structure of mineral balance.

Zinc and copper: the best known pair

Zinc is one of the most popular supplements of all. It can move a lot when a deficiency has been documented. And it has a well-documented shadow.

Observation, review in humans What high-dose zinc over months can do

A systematic review evaluated 34 publications with 37 described cases of blood count changes under zinc exposure, published between 1972 and 2025. The sources were oral supplements, zinc-containing denture adhesive creams and swallowed coins.

The reported daily amounts ranged from around 50 milligrams of elemental zinc to over 1,500 milligrams, and the duration from weeks to years. In every case serum copper was low. Almost all had anaemia, frequently together with a shortage of white blood cells. After stopping zinc and giving copper, the blood count mostly recovered within weeks to months.

A second systematic review collected 198 cases of copper-deficiency damage to the spinal cord. The second most common cause after stomach surgery was excess zinc from denture adhesive. Only a quarter of those affected recovered neurologically.

Dutta A et al. Biol Trace Elem Res. 2026. DOI: 10.1007/s12011-026-05136-z · Chen JW et al. Spine J. 2024. DOI: 10.1016/j.spinee.2024.06.018

An important qualification: these are case reports from the upper end of the dose scale, not a description of what happens with a moderate, time-limited course of zinc. But the mechanism is measurable at far lower amounts too. In a small study in adult women over ten weeks with 50 milligrams of zinc daily, both a copper-dependent enzyme in the red blood cells and ferritin fell in a before and after comparison. There was no placebo group, so the strength of the evidence is limited.

Iron and zinc: competing at the same door

Both metals partly use the same transport routes in the gut. A review from Chile gathered the human data on this. At a low iron dose the threshold for inhibition was at a zinc to iron weight ratio of about 5.9 to 1, and at a higher iron dose already at 1 to 1. Interesting detail: in real meals this effect was often not detectable. The competition shows up mainly when both arrive together, dissolved and on an empty stomach.

Calcium, magnesium and vitamin D: a triangle

This is where it gets interesting, because the three meet not only in the gut but throughout metabolism. Magnesium is a cofactor in the activation of vitamin D, in its transport and in its breakdown. A review in Advances in Nutrition describes how calcium intake in the United States rose considerably faster than magnesium intake between 1977 and 2012. The calcium to magnesium ratio there is now above 3 to 1, while the authors consider a ratio of around 2 to 1 more favourable.

They phrase the consequence carefully, and I join them in that caution: whoever supplements calcium and vitamin D while magnesium intake is low is moving a triangle and not just one corner. How relevant this is clinically has so far been studied directly far too rarely.

Folic acid and vitamin B12: the quietest antagonism

This point is one of the most important and at the same time professionally contested. So I will explain both sides.

The classic concern goes like this: during a simultaneous B12 deficiency, folic acid can make the blood count look unremarkable again while neurological damage continues in the background. The deficiency is then discovered later. This idea shaped the regulatory rules for folic acid for decades.

A detailed review from 2020 worked through the literature from 1945 to 2017 and disagrees in part. The authors argue that the separation between haematological and neurological signs of a B12 deficiency is not well explained by the masking model. They consider the upper limit of one milligram of folic acid per day to be safe.

How I handle this

I do not let a controversy like this push me into inaction. For practice a simple principle is enough: if folate is being supplemented, B12 status belongs in the picture. Not out of fear, but because both work in the same metabolic pathway.

That costs one laboratory value. In case of doubt it spares you a late diagnosis.

Selenium: the window is narrower than many people think

Selenium is a prime example of the fact that with trace elements a deficiency is not the only problem. Too little can do harm, too much as well. Specialists speak of a U-shaped curve.

Clinical trial in humans When selenium showed an unexpected signal

In an American trial in regions with low selenium intake, 1,202 people without diabetes received 200 micrograms of selenium daily or placebo, over an average of 7.7 years.

In the selenium group 58 people developed type 2 diabetes, in the placebo group 39. The hazard ratio was 1.55. A dose-response pattern stood out: those who already had the highest blood selenium levels at baseline carried the highest risk.

An important qualification: diabetes was a secondary endpoint in this work, and the diagnoses largely rested on self-report. That weakens the statement. It is enough, though, to make the case against taking selenium long term without checking.

Stranges S et al. Ann Intern Med. 2007. DOI: 10.7326/0003-4819-147-4-200708210-00175
InteractionWhat can happenWhat follows from it
High-dose zinc over monthsCopper absorption can fall, blood count and nerves can be affectedLimit zinc in time, keep copper status in mind
Zinc and iron together on an empty stomachCompetition for the same transporters in the gutSpace them out or take them with a meal
Calcium and vitamin D without magnesiumThe ratio between the three can shiftConsider magnesium intake from the diet as well
Folic acid with unknown B12 statusThe blood count can look unremarkable, the debate on this is ongoingMeasure B12 when folate is supplemented
Iron during silent inflammationHepcidin can throttle absorption, ferritin can misleadAlways assess together with an inflammation marker
Selenium long term and highThe safety window is narrow, with signals towards metabolismOnly with a baseline value and follow-up

And now you know why it makes me uneasy when someone takes five single-nutrient products in parallel without a single measurement behind them.

Covering requirements and high-dose therapy are two different worlds

Here lies a mix-up that creates a lot of confusion. And it runs in both directions.

On one side there is supplementation in the narrow sense. It covers requirements. It moves in the range of the official reference values. It fills gaps. No therapeutic effect is to be expected from it, and that is not a put-down, it is a description.

On the other side there is therapeutic high-dose use, often called orthomolecular medicine. Here a nutrient is used like a medication. In a clearly higher dose, targeted, for a limited time, under medical supervision and with laboratory monitoring.

This second world is no esoteric fringe. Conventional medicine uses it every day. Thiamine in a high dose in Wernicke encephalopathy. Zinc in a high dose in Wilson disease. Folinic acid as a rescue after methotrexate. Niacin in gram doses in lipidology. Vitamin B6 in certain inherited enzyme defects. In all of these cases the same applies: targeted, supervised, time-limited.

The same substance, two entirely different applications. The difference is called dose, indication and monitoring.

The sharpest example of this difference is vitamin D. I describe it in detail here on purpose, because the whole principle becomes visible in it.

To cover requirements, the German Nutrition Society names a reference value of 800 International Units per day for the case where the body forms no vitamin D of its own. The European Food Safety Authority names 4,000 International Units per day as the tolerable upper intake level for adults. Over-the-counter products move in that order of magnitude. Which amount fits you belongs in the conversation with your doctor.

In the so-called Coimbra protocol for multiple sclerosis and other autoimmune diseases, by contrast, doses in the range of tens of thousands up to over 100,000 International Units daily are used. That comes with a strict calcium restriction, a high fluid intake and close monitoring of calcium in serum and urine, parathyroid hormone and kidney values.

Observation, review in humans What has been published on the safety of the Coimbra protocol

A German group documented laboratory values over up to three and a half years in 319 patients with autoimmune diseases on this protocol. The mean daily dose was 35,291 International Units of vitamin D3.

This was accompanied by a strictly low-calcium diet and a daily fluid intake of at least 2.5 litres. Across more than 6,100 evaluated laboratory parameters, the mean values for serum calcium, creatinine, estimated kidney function and urinary calcium excretion were within the normal range.

An important qualification: the data come from a centre that works according to this protocol itself and is certified for it. Independent safety data do not exist so far. It is a case series, not a randomised trial and not proof of efficacy. The authors themselves stress the requirement of supervision by experienced physicians.

Amon U et al. Nutrients. 2022. DOI: 10.3390/nu14081575
An important safety note on the Coimbra protocol

I describe this approach because it shows the dose principle so clearly. I explicitly do not recommend it here.

It is an experimental therapeutic approach, not an established standard, and it is not recommended in any guideline for the treatment of multiple sclerosis. Without the medical supervision described, hypercalcaemia can develop, with kidney damage as a possible consequence. Self-experimentation with doses like these is dangerous.

What you can take from it is the principle alone: the dose decides whether we are talking about nutrition or about therapy.

How quickly the other direction tips over is shown by a review on vitamin D intoxication. Confusion, apathy, repeated vomiting, abdominal pain, intense thirst and increased urination are among the described signs. As a marker of overdosing the authors name serum levels above 150 nanograms per millilitre. For context: the usual supply range sits far below that, mostly between 30 and 60 nanograms per millilitre. A value clearly above that is not a safety buffer, it is a reason to have the dose reviewed medically.

And an Australian trial shows particularly vividly that more is not better even when the total amount is right.

Clinical trial in humans When the distribution matters more than the amount

2,256 women aged 70 and over with an increased fracture risk received a single annual dose of 500,000 International Units of vitamin D3 or placebo, each autumn or winter over three to five years.

In the vitamin D group more falls occurred than under placebo, and more fractures as well. This stood out particularly in the first three months after the dose.

What this means for you: with fat-soluble vitamins the body evidently does not care for bolus doses. An even, moderate intake can be gentler on the feedback loop than a flood.

Sanders KM et al. JAMA. 2010. DOI: 10.1001/jama.2010.594

A similar picture emerges with vitamin B6. The exact threshold is disputed, and honesty requires saying so. A review in an American journal describes a narrow therapeutic range, yet explicitly considers the link between raised pyridoxine levels and nerve damage to be poorly established. It recommends the activated form pyridoxal-5-phosphate and less frequent rather than daily dosing. Alongside this there are case reports in which gait disturbances improved after stopping an over-the-counter product containing B6.

The underestimated addition effect

Vitamin B6 sits in a great many combination products. In the B complex, in the multivitamin, in the sports drink, in the nerve formula. Each one on its own looks unremarkable.

If you take three of them in parallel, the amounts add up. That is exactly how the cases arise that later get reported in journals. A look at all the labels at once can do more here than any further capsule.

And now you know why I never skip the question of dose, not even with a vitamin that has a reputation for being harmless.

Real food first, and not as a platitude

If you have read this far, you can already sense where this is going.

Nutrient supply from natural, real foods of good origin and good husbandry is always the first choice. That is not a romantic sentence. It has a physiological reason.

A food never gives you a nutrient on its own. It gives it to you embedded in a matrix. In fibre, in fats that make the absorption of fat-soluble vitamins possible, in plant compounds, in other minerals in a ratio that grew that way. This matrix helps determine how much arrives and how quickly.

This is probably where part of the explanation for the disappointing antioxidant trials lies. Observational data show a link between plenty of fruit and vegetables and fewer diseases. When a single substance is then isolated from that and given in a high dose, it behaves differently. Beta carotene is the best known example.

No supplement replaces nutrition, sleep, movement, sunlight and relationship. A capsule can fill a gap. It cannot replace a foundation.

I do not say this to lecture you. I say it because I keep meeting people who spend a lot of money on products while sleeping five hours. That order of priorities costs strength and money at the same time.

The freedom thought

This is not about capsules. It is about whether you can get up in the morning without having to force yourself. Whether you have something left in the evening for the people who matter to you. Whether your head is clear enough for the decisions that are waiting.

That is not an optimisation topic. That is room to act in your own life.

And now you know why in my consultation the question about breakfast often comes before the question about the product.

And why targeted topping up can be more often justified today

At this point you might think: so just eat well and everything is fine. Unfortunately it is not that simple, and this section matters to me.

There are four developments that have changed the equation. I present them with their limits, not as a scandal story.

First: soils, cultivars and harvest times have changed

Database comparison What the comparison of old and new nutrient data shows

An American group compared nutrient data from the US Department of Agriculture for 43 garden crops between 1950 and 1999, for 13 nutrients and water content.

As a group the foods showed statistically reliable declines in six nutrients: protein, calcium, phosphorus, iron, riboflavin and ascorbic acid. The declines in the median values ranged from 6 percent for protein to 38 percent for riboflavin. For seven further nutrients no reliable change was found.

An important qualification, and the authors say it themselves: looking at individual foods, the values mostly cannot be reliably distinguished from no change at all. About 28 percent of the ratios were even above one, showing an increase. As an explanation the authors point mainly to changed cultivars with a trade-off between yield and nutrient content.

Davis DR, Epp MD, Riordan HD. J Am Coll Nutr. 2004. DOI: 10.1080/07315724.2004.10719409

I show you this study with its limitations, because in advertising copy it is often quoted as proof of empty soils. It does not support that. The comparability of analytical methods over 50 years is methodologically contested, and part of the effect is explained by the dilution effect in high-yield cultivars. What it does support is a hint: the assumption that an apple today is the same apple as in 1950 is not a given.

Second: the share of heavily processed foods is high

Ultra-processed products deliver energy reliably. With micronutrient density it looks different.

Observation, review in humans Degree of processing and nutrient density

A Portuguese group evaluated the national dietary survey from 2015 and 2016 and classified all foods by their degree of processing.

In adults, the ultra-processed share contained considerably less of almost all the vitamins examined than the unprocessed or minimally processed share. Those who ate the highest share of ultra-processed products more often had an inadequate intake of vitamin B6, vitamin C, folate, magnesium, zinc and potassium.

An important qualification: this is a cross-sectional study. It shows an association, not a cause. In the older participants the link with nutrient density was not detectable.

Antoniazzi L et al. Eur J Nutr. 2022. DOI: 10.1007/s00394-022-03057-w

Third: environmental exposure and chronic stress can raise consumption

Heavy metals, mould toxins, plasticisers and pesticide residues are present in the environment. The body meets them with detoxification and protection systems. These systems work with cofactors such as zinc, selenium, magnesium, glutathione precursors and B vitamins.

The same could apply to chronic stress. A permanently active stress axis can raise the requirement for cofactors and increase excretion through the kidney. Solid human studies that put a number on this extra requirement are, however, scarce. What I describe here is a physiological consideration, not a documented effect.

Fourth: medications can deplete nutrients

This is the best documented of the four points, and of all things the one discussed least.

Observation, review in humans Proton pump inhibitors and vitamin B12

A Californian group compared 25,956 people with a newly diagnosed vitamin B12 deficiency with 184,199 people without that finding. Those who had been prescribed proton pump inhibitors for at least two years carried a higher risk, with an odds ratio of 1.65. Higher daily doses went along with a stronger association.

An important qualification: this is a case-control study. It shows an association, not a cause.

Lam JR et al. JAMA. 2013. DOI: 10.1001/jama.2013.280490
Clinical trial in humans Metformin and vitamin B12

In a randomised trial in the Netherlands, 390 people with type 2 diabetes received metformin or placebo over 4.3 years. B12 levels under metformin fell by an average of 19 percent compared with placebo. Homocysteine showed an upward trend that was not statistically robust. The authors recommend regular B12 checks during long-term metformin therapy.

What this means for you: this is not an argument against these medications. They have their rightful place. It is an argument for keeping nutrient status in mind when they are taken long term.

de Jager J et al. BMJ. 2010. DOI: 10.1136/bmj.c2181

Further examples are discussed in the literature: diuretics and potassium or magnesium, statins and coenzyme Q10, hormonal contraception and B6, B12, folate and zinc. The strength of the data varies considerably.

The core sentence of this section

Targeted topping up can be more often justified today, and not because supplements happen to be in fashion. It is because the conditions have changed.

That is an argument for precision, not for more capsules. A changed environment means: look more closely. It does not mean: take everything across the board.

And now you know why in every new conversation I ask about the medication list first.

The four lenses: why a nutrient never plays just one part

In clinical psychoneuroimmunology we look at a symptom through four lenses. With micronutrients that is not a detour, it is simply cell biology.

The reason is simple: most micronutrients are not active agents, they are cofactors. They do nothing themselves. They make it possible for enzymes to do something. And these enzymes sit in quite different systems at the same time.

Nervous system

B vitamins, magnesium, iron and zinc are involved in the production and breakdown of messenger substances. A B12 deficiency can show itself neurologically before the blood count changes. This is precisely why a late diagnosis can have consequences here.

Immune system

Zinc, selenium and vitamin D are involved in regulating immune responses. At the same time inflammation itself changes nutrient balance: hepcidin rises, ferritin rises, serum zinc falls. Cause and consequence are often hard to separate here.

Metabolism

In the respiratory chain of the mitochondria, iron, copper, coenzyme Q10 and several B vitamins work together. If one link is missing, energy production can suffer. That is one of the reasons why deficiencies often show up first as diffuse exhaustion.

Hormone system

The thyroid needs iodine, selenium and iron to build and convert its hormones. Under sustained load the stress axis consumes magnesium and B vitamins. A single value can rarely be judged sensibly here without the rest.

These four lenses explain why the same nutrient turns up in quite different guides. With sleep, with exhaustion, with hair loss, with mood, with susceptibility to infection. Not because it is good for everything. But because a cofactor that runs along in many enzyme reactions can make itself noticed in many places when it runs short.

And they explain the flip side. When you pull on one lens, the others move with it. That is exactly the reason for the antagonisms from section three.

Reframe

Holistic does not mean giving everything at once. Holistic means thinking, before giving one substance, about which four systems will move along with it.

That is more demanding than a list of recommendations. But it is how I can take responsibility for this.

Three levers you can put into practice today

No protocol, no brands, no dosing recommendation. Just three things that lie in your hands and cost nothing.

Before that, the three questions I ask myself with every single product. They are the core of this whole article.

Question 1

Have I measured a deficiency?

Not suspected, not inferred from a symptom, but measured. And with the appropriate marker, not with just any value.

If the answer is no, that is not a ban. It is a hint that you are currently guessing.

Question 2

What is my goal?

What exactly should be different, and how would I notice it? A laboratory value? Sleep? Stamina in the afternoon?

Without a goal there is no yardstick. And without a yardstick the intake runs on indefinitely.

Question 3

When do I stop again?

This question is almost never asked, and it is the most important one. When do I check, and what do I make the decision to continue depend on?

Supplements are as a rule a time-limited intervention, not a lifelong subscription.

The exceptions

When long-term intake can be justified

Vitamin B12 after stomach surgery. Vitamin D in winter at our latitudes. Targeted substitution in a chronic absorption disorder.

All three situations require medical assessment and an indication set by a doctor. They are examples from treatment, not a recommendation to take them on your own.

These are well-founded exceptions with a clear indication. They are no argument for taking everything permanently.

Lever 1: put everything on the table and add it up

  • Get every tin, every powder and every combination product out of the cupboard. The sports drink and the nutrient shake too.
  • Write down for each product which vitamins and minerals it contains and in what amount. The nutrition table on the back has the numbers.
  • Add up the substances that appear more than once. With vitamin B6, zinc, selenium and vitamin D this calculation is especially worthwhile.
  • Take this list to your next appointment. It often says more than any description from memory.

Lever 2: write one sentence for every product

  • The sentence goes: I take X because Y was measured, with the goal Z, and I will check in month A.
  • Anything where you cannot fill in that sentence is a candidate for a conversation. Not automatically for the bin, but for a rethink.
  • This exercise takes ten minutes. In my consultation it often ends with at least one product turning out to be dispensable.

Lever 3: build the foundation before you repair the roof

  • Sleep, daylight in the morning, movement, protein with every meal and real food instead of heavily processed products.
  • These five points are unspectacular and they are the basis on which any supplement can do anything at all.
  • If you had to choose between a new capsule and going to bed half an hour earlier, the decision is usually clear.
Important safety note

Supplements are not automatically harmless just because they are sold over the counter. A few points that belong in medical hands: with impaired kidney function, magnesium, potassium and vitamin D can accumulate. With liver disease, caution is needed with fat-soluble vitamins. Vitamin K can influence the effect of vitamin K antagonists such as phenprocoumon and warfarin, and here agreement with the treating practice is mandatory.

Iron belongs to be supplemented only when a deficiency has been measured, because the body has no active route to get rid of an excess again. Separate upper limits apply to children and adolescents, and products for adults are not suitable for them. Iron-containing products belong out of reach of small children, since even a few tablets can become dangerous for a small child.

Calcium, magnesium, zinc and iron can impair the absorption of certain antibiotics and of thyroid hormones, which is why spacing them out makes sense. In pregnancy and breastfeeding, separate rules apply, both for vitamin A and for iodine and folate. For vitamin B6, selenium, zinc and vitamin D, authorities such as the European Food Safety Authority and the German Federal Institute for Risk Assessment name tolerable upper intake levels, which can easily be exceeded when several products are used at the same time.

This text does not replace a medical examination, a diagnosis or individual advice. Please discuss every higher dose and every long-term intake with a doctor who knows your values and your medications.

And now you know why my answer to the question of whether supplements make sense begins with a question back: sensible for what, in whom, and for how long?

Common questions about supplements and homeostasis

Do supplements make sense, or are they a waste of money?

Both happen, and the difference rarely lies in the product. It lies in the question that comes before it.

If a nutrient is demonstrably low and you top it up on purpose, that can change something. If you supplement broadly and without measuring, the large prevention trials show no average benefit. The Cochrane analysis on antioxidants with 296,707 participants found no advantage for mortality, and for beta carotene and vitamin E in the trials with a low risk of bias it even found a signal in the unfavourable direction.

That does not mean supplements are useless. It means the watering can is the wrong tool.

Why do the large multivitamin trials show no benefit?

Because they mostly never measured nutrient status at baseline. Whether the participants had a gap at all therefore remains open. Someone who is full does not get fuller from another meal.

In three large US cohorts with 390,124 adults, taking a multivitamin was not associated with lower mortality. At the same time the picture is not uniform. In the Physicians Health Study II with 14,641 doctors, the overall cancer rate under a daily multivitamin was slightly lower, and a meta-analysis of three sub-studies within COSMOS found a small advantage for memory performance. Small, but measurable.

In short: as a blanket way to extend life the multivitamin does not deliver, as a targeted tool for a documented gap it can make sense.

What does homeostasis mean when it comes to nutrients?

Homeostasis means that your body does not store values, it regulates them. For almost every nutrient it has a feedback loop with sensors, transporters and brakes.

Iron is a good example. The hormone hepcidin binds to ferroportin, the only known iron exporter, and can throttle absorption in the gut when inflammation is present. So you can swallow more without more arriving.

A nutrient is therefore not a switch you flip. It is one player in a network that responds to every change.

Which nutrients get in each other's way?

The best known pairs are zinc and copper, iron and zinc, calcium and magnesium, and folic acid and vitamin B12.

Zinc taken in high doses over months can push down copper status. A systematic review of 34 publications with 37 described cases showed changes in the blood count under high zinc intake, and serum copper was low in every case. Zinc and iron compete for the same transport routes in the gut, and in a fasting solution an inhibition appeared above certain ratios.

Folic acid can also make the blood count look unremarkable during a B12 deficiency while the neurological side keeps progressing. How far this masking effect reaches is a matter of ongoing debate in the literature.

What is the difference between supplementation and orthomolecular medicine?

The difference is the dose, and with it the whole logic behind it.

Supplementation in the narrow sense covers requirements. It fills gaps, works in the range of the official reference values and needs no close monitoring. Orthomolecular or therapeutic high-dose use treats a nutrient like a medication, in a clearly higher dose, for a limited time and with laboratory monitoring.

One example from conventional medicine is thiamine in Wernicke encephalopathy. A capsule from an online shop is not expected to have a therapeutic effect, and that is not a criticism, it is a description of the order of magnitude.

Can you take supplements permanently?

In most cases a supplement is a time-limited intervention with a goal and a follow-up date, not a lifelong subscription.

In practice I like to suggest thinking about the end right at the start: baseline lab work, time frame, check-up, decision. There are well-founded exceptions. Vitamin B12 after stomach surgery, vitamin D in winter at our latitudes, or targeted substitution in a chronic absorption disorder belong on that list. All three require medical assessment and an indication set by a doctor.

And that is exactly what they are: well-founded exceptions, not the rule. Long-term intake without monitoring is the setting in which antagonisms build up quietly.

Is a healthy diet still enough today?

Real food from good sources remains the first choice, nothing changes that. Foods deliver nutrients in a matrix of cofactors, fibre and plant compounds that no capsule reproduces.

At the same time the conditions have shifted. A comparison of USDA data on 43 garden crops between 1950 and 1999 found statistically reliable declines for six nutrients, and the authors explain this mainly through changed cultivars and a dilution effect from higher yields. Add to that the high share of ultra-processed foods. In a Portuguese survey a higher share of such products was associated with a lower vitamin and mineral density.

So topping up can be justified, but it does not replace the diet.

Which medications can affect nutrient balance?

Some of the most frequently prescribed medications interfere with nutrient pathways.

In a case-control study with around 26,000 people with a newly diagnosed B12 deficiency, a prescription of proton pump inhibitors for at least two years was associated with a higher risk. In a randomised trial over 4.3 years, B12 levels under metformin fell by an average of 19 percent compared with placebo. Diuretics, hormonal contraception and statins are discussed in this context as well.

One important point: this is no reason to stop a prescribed medication. It is a reason to discuss nutrient status with the doctor treating you.

Can too much of a vitamin do harm?

Yes, and this is the most underestimated point in the whole field.

With vitamin D, a permanently excessive intake can lead to hypercalcaemia, with confusion, vomiting, intense thirst and strain on the kidneys. Review articles name serum levels above 150 nanograms per millilitre as a marker of overdosing. For context: the usual supply range sits far below that, mostly between 30 and 60 nanograms per millilitre. With vitamin B6, sensory nerve damage is described at very high doses, although the literature places the threshold inconsistently.

And more is not automatically better: a single annual dose of 500,000 International Units of vitamin D in 2,256 older women was associated with more falls and fractures than placebo in a randomised trial.

Which values should I have measured before I supplement?

That depends on your question, which is why there is no list here that fits everyone. A useful principle: first the question, then the test, then the product.

When exhaustion is the theme, iron status together with an inflammation marker, thyroid values, vitamin D and B12 with functional markers are common starting points. Context matters: ferritin on its own can be misleading during silent inflammation, because it is an acute phase protein.

Discuss the selection with your doctor so that the values fit your situation and not a marketing promise.

How this topic connects to the others

This article is the starting point. If you want to go deeper at a particular place, these paths lead onward.

SJ

Shukri Jarmoukli

Physician · Area of focus: integrative medicine · ViveCura Berlin

I work at the intersection of conventional medicine, clinical psychoneuroimmunology and lifestyle medicine. I am less interested in which product happens to be in fashion than in what a symptom tells us about the whole system.

My texts deliberately separate what studies document from what I observe clinically. Both have their place, but not the same one.

Private practice ViveCura · Skalitzer Straße 137, Berlin

Sources

  1. Loftfield E, O'Connell CP, Abnet CC et al. Multivitamin Use and Mortality Risk in 3 Prospective US Cohorts. JAMA Netw Open. 2024;7(6):e2418729. DOI: 10.1001/jamanetworkopen.2024.18729 [Cohort, n=390,124]
  2. Gaziano JM, Sesso HD, Christen WG et al. Multivitamins in the prevention of cancer in men: the Physicians' Health Study II randomized controlled trial. JAMA. 2012;308(18):1871-1880. DOI: 10.1001/jama.2012.14641 [RCT, n=14,641]
  3. Vyas CM, Manson JE, Sesso HD et al. Effect of multivitamin-mineral supplementation versus placebo on cognitive function: results from the clinic subcohort of COSMOS and meta-analysis of 3 cognitive studies within COSMOS. Am J Clin Nutr. 2024;119(3):692-701. DOI: 10.1016/j.ajcnut.2023.12.011 [Meta-analysis, k=3, n=5,203]
  4. Bjelakovic G, Nikolova D, Gluud LL, Simonetti RG, Gluud C. Antioxidant supplements for prevention of mortality in healthy participants and patients with various diseases. Cochrane Database Syst Rev. 2012;2012(3):CD007176. DOI: 10.1002/14651858.CD007176.pub2 [Meta-analysis, k=78, n=296,707]
  5. The Alpha-Tocopherol, Beta Carotene Cancer Prevention Study Group. The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. N Engl J Med. 1994;330(15):1029-1035. DOI: 10.1056/NEJM199404143301501 [RCT, n=29,133]
  6. Klein EA, Thompson IM, Tangen CM et al. Vitamin E and the risk of prostate cancer: the Selenium and Vitamin E Cancer Prevention Trial (SELECT). JAMA. 2011;306(14):1549-1556. DOI: 10.1001/jama.2011.1437 [RCT, n=35,533]
  7. US Preventive Services Task Force. Vitamin, Mineral, and Multivitamin Supplementation to Prevent Cardiovascular Disease and Cancer: US Preventive Services Task Force Recommendation Statement. JAMA. 2022;327(23):2326-2333. DOI: 10.1001/jama.2022.8970 [Authority Document]
  8. Dutta A, Chaudhary V, Kumari S et al. Zinc-Induced Hematologic Toxicities: A Systematic Review of Descriptive Studies. Biol Trace Elem Res. 2026;204(9):6628-6642. DOI: 10.1007/s12011-026-05136-z [Systematic Review, k=34]
  9. Chen JW, Zeoli T, Hughes NC, Lane A, Berkman RA. Copper deficiency myelopathy mimicking cervical spondylitic myelopathy: a systematic review of the literature with case report. Spine J. 2024;24(11):2026-2034. DOI: 10.1016/j.spinee.2024.06.018 [Systematic Review, k=116]
  10. Yadrick MK, Kenney MA, Winterfeldt EA. Iron, copper, and zinc status: response to supplementation with zinc or zinc and iron in adult females. Am J Clin Nutr. 1989;49(1):145-150. DOI: 10.1093/ajcn/49.1.145 [Intervention study without placebo group, 10 weeks]
  11. Olivares M, Pizarro F, Ruz M, López de Romaña D. Acute inhibition of iron bioavailability by zinc: studies in humans. Biometals. 2012;25(4):657-664. DOI: 10.1007/s10534-012-9524-z [Review]
  12. Afsar RE, Kanbay M, Ibis A, Afsar B. In-depth review: is hepcidin a marker for the heart and the kidney? Mol Cell Biochem. 2021;476(9):3365-3381. DOI: 10.1007/s11010-021-04168-4 [Mechanism Review]
  13. Stranges S, Marshall JR, Natarajan R et al. Effects of long-term selenium supplementation on the incidence of type 2 diabetes: a randomized trial. Ann Intern Med. 2007;147(4):217-223. DOI: 10.7326/0003-4819-147-4-200708210-00175 [RCT, n=1,202]
  14. Rosanoff A, Dai Q, Shapses SA. Essential Nutrient Interactions: Does Low or Suboptimal Magnesium Status Interact with Vitamin D and/or Calcium Status? Adv Nutr. 2016;7(1):25-43. DOI: 10.3945/an.115.008631 [Review]
  15. Marcinowska-Suchowierska E, Kupisz-Urbańska M, Łukaszkiewicz J, Płudowski P, Jones G. Vitamin D Toxicity, A Clinical Perspective. Front Endocrinol (Lausanne). 2018;9:550. DOI: 10.3389/fendo.2018.00550 [Review]
  16. Sanders KM, Stuart AL, Williamson EJ et al. Annual high-dose oral vitamin D and falls and fractures in older women: a randomized controlled trial. JAMA. 2010;303(18):1815-1822. DOI: 10.1001/jama.2010.594 [RCT, n=2,256]
  17. Amon U, Yaguboglu R, Ennis M, Holick MF, Amon J. Safety Data in Patients with Autoimmune Diseases during Treatment with High Doses of Vitamin D3 According to the Coimbra Protocol. Nutrients. 2022;14(8):1575. DOI: 10.3390/nu14081575 [Case series, n=319]
  18. Reddy P. Preventing Vitamin B6-Related Neurotoxicity. Am J Ther. 2022;29(6):e637-e643. DOI: 10.1097/MJT.0000000000001460 [Review]
  19. Malet L, Dayot L, Moussy M, de la Gastine B, Goutelle S. Peripheral neuropathy with hypervitaminosis B6 caused by self-medication. Rev Med Interne. 2020;41(2):126-129. DOI: 10.1016/j.revmed.2019.11.003 [Case report]
  20. van Gool JD, Hirche H, Lax H, De Schaepdrijver L. Fallacies of clinical studies on folic acid hazards in subjects with a low vitamin B12 status. Crit Rev Toxicol. 2020;50(2):177-187. DOI: 10.1080/10408444.2020.1727842 [Review]
  21. Lam JR, Schneider JL, Zhao W, Corley DA. Proton pump inhibitor and histamine 2 receptor antagonist use and vitamin B12 deficiency. JAMA. 2013;310(22):2435-2442. DOI: 10.1001/jama.2013.280490 [Case-control study, n=210,155]
  22. de Jager J, Kooy A, Lehert P et al. Long term treatment with metformin in patients with type 2 diabetes and risk of vitamin B-12 deficiency: randomised placebo controlled trial. BMJ. 2010;340:c2181. DOI: 10.1136/bmj.c2181 [RCT, n=390]
  23. Davis DR, Epp MD, Riordan HD. Changes in USDA food composition data for 43 garden crops, 1950 to 1999. J Am Coll Nutr. 2004;23(6):669-682. DOI: 10.1080/07315724.2004.10719409 [Database comparison, 43 garden crops]
  24. Antoniazzi L, de Miranda RC, Rauber F et al. Ultra-processed food consumption deteriorates the profile of micronutrients consumed by Portuguese adults and elderly: the UPPER project. Eur J Nutr. 2022;62(3):1131-1141. DOI: 10.1007/s00394-022-03057-w [Cross-sectional study, nationally representative]
Transparency on the evidence The hard data in this text concern two areas above all: the large prevention trials and the documented interactions at high doses. Both are well established. The evidence is considerably thinner where the practical consequence lies: for the targeted use of a single nutrient in a documented deficiency with a defined goal there are far fewer large randomised trials than one would expect. Part of what is described here therefore rests on physiological foundations, review articles, case series and cross-sectional data. That is biologically plausible, but not established with the same certainty as a result from a large randomised trial. The doses named are without exception figures from studies or official reference values, never a personal recommendation. This text does not replace a medical examination, a diagnosis or individual advice.

Have questions or want to book an appointment?

We'd be happy to advise you personally at our practice.

Book appointment